Camolyn Eye Drop and Fisiolin Nasal Drop Recall: Drops May Be Non-Sterile

|

A recall of all Camolyn Eye Drops and Fisiolin Nasal Drops has been issued after it was discovered that they may not be sterile, which could cause infections or blindness. 

The nasal and eye drop recall was announced on Wednesday by FDA. According to a press release from the manufacturer, US Oftalmi Corporation, the recall was initiated after it was determined that conditions in the manufacturing facility could not guarantee the sterility of the drops. However, there have been no injuries or reports of problems from consumers.

The Camolyn Eye Drops recall and Fisiolin Nasal Drops recall affects all over-the-counter drops under those labels, including Camolyn Homeopathic; Camolyn Plus, Naphazoline + Chamomile; Camolyn Refresh; Camolyn-A, Naphazoline + Pheniramine; and Fisiolin Nasal Drops Sodium Chloride Pediatric Uses. All of the recalled eye drops and nasal drops were distributed nationwide to food and drug distributors and were packaged in 15 mL plastic bottles.

Sports-Betting-Addiction-Lawsuits
Sports-Betting-Addiction-Lawsuits

If a consumer uses non-sterile drops, they could develop an infection. Some eye infections could potentially lead to blindness. However, US Oftalmi has said that it believes the likelihood of users experience a severe adverse reaction is remote.

The company has ceased production of the nasal and eye drops until the manufacturing problem can be solved. It is recommended that any consumers with the recalled eye and nasal drops discard them immediately.

Anyone who experiences an adverse reaction from this product should report the incident to the FDA’s MedWatch Program at www.fda.gov/medwatch.


0 Comments


Share Your Comments

This field is hidden when viewing the form
I authorize the above comments be posted on this page
Post Comment
Weekly Digest Opt-In

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

MORE TOP STORIES

A special mediator has been appointed to oversee negotiations between Johnson & Johnson and tens of thousands of women who say its talcum powder products caused them to develop reproductive system cancers.